Table 1 Operationalisation of BCTs in Pro-M study
BCTs identified from modified Delphi study [37] | Context during phase 1 prototype development | Operationalizing BCTs in the Pro-M Study |
|---|---|---|
Credible source | Pharmacists who are experienced in geriatric pharmacology | Medication reviews are led by pharmacists, who will be present at the clinic during review sessions |
Restructuring the physical environment | Presence of pharmacist in clinics | |
Instruction on how to perform the behaviour | Guidelines to assist in optimizing prescribing | Pharmacists will conduct medication review using prescribing tools (e.g., Beers Criteria) |
Information about health consequences | Feedback from pharmacists on occurrence of PIMs post-medication review | Physicians will receive patient-specific feedback on PIMs or other medication issues identified by pharmacists |
Feedback on outcomes of behaviour | ||
Problem solving | Physicians will identify medication problems and/or discrepancies, and then discussing with pharmacists as well as patients for necessary changes to be made | Physicians will ascertain medication review outcomes and any recommendations from the pharmacists, before making the next prescribing decision (e.g., to reduce PIMs) |
Goal setting (outcome) | ||
Goal setting (outcome) | Ensuring proper documentation on reasons behind addition or removal of medications and provide feedback to other relevant prescribers | Documentation of medication indications and communicating changes to other relevant prescribers |
Feedback on outcomes of behaviour |